Expression of nm23 antimetastatic gene product in head and neck squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The nm23 gene is recognized as a suppressor gene regulating cancer cell metastasis.
• Lower nm23 gene product levels correlate with higher metastatic potential in various cancers, including human breast, colorectal, and lung carcinomas.
• Nodal status is a critical prognostic factor in head and neck cancers.

Purpose of the Study:

• To investigate the relationship between nm23 gene product expression and lymph node metastasis in patients with head and neck squamous cell carcinomas.
• To assess if nm23 expression levels correlate with nodal status in this patient cohort.

Main Methods:

• Pilot study involving 70 consecutive patients with head and neck squamous cell carcinomas.
• Immunohistochemical staining of tumor tissues using a monoclonal antibody against the nm23-H1 peptide sequence.
• Scoring of nm23 immunoreactivity (0-2) by two independent observers and comparison with nodal status.

Main Results:

• Reduced nm23 immunoreactivity (grades 0 and 1) was found in 88% of patients with positive lymph node metastasis (N=34).
• Strong nm23 immunoreactivity (grade 2) was observed in 56% of patients with negative lymph node status (N=36).
• A statistically significant association was observed between reduced nm23 gene product expression and the presence of lymph node metastasis (P = 0.0006).

Conclusions:

• This study indicates a significant correlation between reduced nm23 gene product expression and positive lymph node metastasis in head and neck squamous cell carcinomas.
• While nm23 expression levels differ based on nodal status, no significant impact on patient survival was demonstrated in this pilot study.
• Further extensive studies are warranted to validate these preliminary findings and explore the prognostic implications of nm23 expression in head and neck cancer.